CTS-Clinical and Translational Science

Papers
(The H4-Index of CTS-Clinical and Translational Science is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Gene polymorphism and prediction of toxicity to platinum‐based chemotherapy in patients with gynecologic cancer569
Intradermal substance P as a challenge agent in healthy individuals215
The impact of skin color and tone on histamine iontophoresis and Doppler flowmetry measurements as a pharmacodynamic biomarker147
A comprehensive Thai pharmacogenomics database (TPGxD‐1): Phenotype prediction and variants identification in 942 whole‐genome sequencing data121
Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection95
Patient, industry, and regulatory perspective on antibody‐drug conjugates dose optimization88
Issue Information80
76
ST2 and CSF‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study73
A Patient Centric Model for Vaso‐Occlusive Crises in Sickle Cell Disease—Outcomes of a Consensus Exercise Conducted Across Patients and Experts70
Developing a clinical research infrastructure embedded in an academic medicine center that equitably supports future clinician scientists63
Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community61
Pharmacokinetics and Toxicity of Dimethylacetamide and Its Metabolite in Pediatric Patients Treated With High Dose Intravenous Busulphan58
Using partition analysis as a facile method to derive net clearances54
Clinician Satisfaction With Pharmacogenomics Clinical Services at a Multistate Health System50
Issue Information49
48
First, Do No Harm: Addressing AI's Challenges With Out‐of‐Distribution Data in Medicine46
Mitigating ipatasertib‐induced glucose increase through dose and meal timing modifications46
First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome43
The Effect of Diabetes Medication on the Scores of the GNRI and CONUT Nutritional Indices: Cross‐S39
Japanese Phase 1 Study for Global Development of Anti‐TL1A Antibody PF‐06480605: A Randomized, Placebo‐Controlled, Single‐Ascending Dose Study38
CYP3A Genotype Is Associated With Variability in the Exposure and Clearance of the Novel Oncogenic Transcription Inhibitor Lurbinectedin38
Expanding regulatory science: Regulatory complementarity and reliance38
Nontraditional Factors Influencing Cardiovascular Disease Risk: Correlation Among Framingham Risk Score, Body Composition Index, and Sleep‐Breathing Monitoring Index37
Issue Information36
Clinical and Economic Impact of Expanded TPMT Testing to Prevent Thiopurine‐Induced Myelosuppression in Australia: A Budget Impact Analysis34
Glucocorticoid‐Induced Tumor Necrosis Factor Receptor Ligand: Correlation and Therapeutic Potential for Cognitive Impairment in Temporal Lobe Epilepsy33
Integrative Use of Ningmitai Capsule and Cefoxitin in Treating Post‐Ureteroscopic Lithotripsy Stent‐Related Urinary Tract Infections31
Risk factors for the development of sepsis in patients with cirrhosis in intensive care units31
Pharmacogenetics of Mycophenolic Acid in Patients of African Descent: Underrepresentation of African Data30
Generalizability in real‐world trials30
Simulated Y‐Site Compatibility of Calcium Gluconate and Benzylpenicillin With Maintenance Fluid Used in Neonatal Intensive Care Unit30
0.093585968017578